의약품 공급망 AI 시장 : 컴포넌트별, 기술별, 공급망 단계별, 도입 형태별, 최종 사용자별, 지역별 - 시장 규모, 업계 동향, 기회 분석 및 예측(2026-2035년)

The AI in pharmaceutical supply chain market is experiencing substantial and accelerating demand across the global healthcare landscape. In 2025, the market is valued at approximately USD 2.88 billion, reflecting the growing recognition of artificial intelligence as a strategic enabler of supply chain efficiency and resilience. As pharmaceutical networks become increasingly globalized and complex, companies are investing heavily in intelligent technologies to modernize operations and improve end-to-end visibility. This strong momentum is expected to continue over the coming decade, with the market projected to reach approximately USD 25.05 billion by 2035, expanding at a remarkable compound annual growth rate (CAGR) of 24.15% during the forecast period from 2026 to 2035.

A primary driver of this rapid growth is the urgent need to reduce the significant financial losses associated with drug waste and supply shortages. Each year, pharmaceutical companies and healthcare systems collectively lose billions of dollars due to expired inventory, improper storage conditions, inaccurate demand forecasting, and distribution inefficiencies. At the same time, shortages of critical medications can have severe consequences for patient care, leading to treatment delays and compromised health outcomes. These challenges have highlighted the limitations of traditional supply chain management approaches and accelerated the adoption of AI-powered solutions.

Noteworthy Market Developments

The AI in pharmaceutical supply chain market is moderately fragmented and highly competitive, characterized by the presence of both global technology hyperscalers and specialized supply chain solution providers. Microsoft holds a dominant position in the market by leveraging its expansive Azure cloud infrastructure. IBM strengthens its competitive position through its advanced analytics platform powered by Watson.

Amazon Web Services (AWS) plays a crucial role in ensuring high availability and scalability for critical pharmaceutical applications. Oracle Corporation maintains a strong foothold in the market through its deeply entrenched enterprise database and resource planning systems. SAP commands a significant share of the market by offering specialized logistics and supply chain modules tailored to pharmaceutical requirements.

Core Growth Drivers

The AI in pharmaceutical supply chain market is witnessing strong and expanding demand across global healthcare ecosystems, driven by the increasing need for efficiency, transparency, and resilience in drug production and distribution networks. As pharmaceutical operations become more complex and globally interconnected, organizations are under growing pressure to modernize their supply chain capabilities using advanced digital technologies. AI has emerged as a key enabler in this transformation, helping stakeholders across the value chain manage uncertainty, reduce inefficiencies, and ensure the timely availability of essential medicines.

Emerging Opportunity Trends

The AI in pharmaceutical supply chain market is increasingly driven by the adoption of highly accurate predictive analytics, which has become a core capability for improving efficiency and reducing operational costs. As pharmaceutical supply chains grow more complex and globally distributed, organizations are relying on intelligent systems to anticipate demand patterns, optimize resource allocation, and minimize inefficiencies across multiple stages of the value chain. This shift toward data-driven decision-making is enabling companies to move away from reactive planning models and toward more proactive, forecast-based strategies.

Barriers to Optimization

Regulatory and compliance hurdles are expected to act as a significant restraint on the growth of AI in pharmaceutical supply chain market. The pharmaceutical industry operates under some of the most stringent regulatory frameworks in the world, where adherence to Good Practice (GxP) guidelines is mandatory across manufacturing, distribution, and quality assurance processes. These regulations are designed to ensure that every stage of the pharmaceutical lifecycle is controlled, documented, and verifiable, leaving little room for uncertainty or undocumented decision-making.

Detailed Market Segmentation

By technology, machine learning held a leading position in 2025, accounting for a substantial share of approximately 30%. This dominance reflects the increasing reliance on advanced data-driven systems to manage the complexity and uncertainty inherent in global pharmaceutical supply networks. As supply chains become more interconnected and data-intensive, machine learning has emerged as a foundational technology enabling organizations to extract meaningful insights from large and diverse datasets.

By supply chain stage, demand forecasting held the leading position in the AI in pharmaceutical supply chain market in 2025, accounting for a significant share of approximately 24%. This dominance reflects the increasing importance of accurately anticipating medication requirements in a highly complex and volatile healthcare environment. Pharmaceutical supply chains operate under strict constraints where both shortages and overstock situations can have serious consequences, ranging from patient treatment delays to substantial financial losses and inventory inefficiencies.

By deployment, cloud-based architectures clearly dominated the AI in pharmaceutical supply chain market in 2025, accounting for an overwhelming share of approximately 72%. This strong preference for cloud deployment reflects a broader structural shift within the pharmaceutical and life sciences industries toward more flexible, scalable, and interconnected digital ecosystems. As supply chains become increasingly global and data-intensive, organizations are prioritizing platforms that enable seamless access to real-time information across geographically dispersed operations.

By end user, pharmaceutical manufacturers led the adoption of AI in the pharmaceutical supply chain market, accounting for a dominant share of approximately 45% in 2025. This leading position reflects the central role manufacturers play in ensuring the continuous production and distribution of essential medicines across global markets. Their operations are highly sensitive to disruptions, as even minor delays in raw material procurement or logistics can immediately halt manufacturing cycles and impact downstream supply availability. Given these high operational stakes, pharmaceutical manufacturers have become the primary drivers of investment in advanced AI-enabled supply chain solutions.

Segment Breakdown

By Component

• Software
• Services

By Technology

• Machine Learning
• Deep Learning
• Predictive Analytics
• Natural Language Processing
• Computer Vision
• Generative AI

By Supply Chain Stage

• Procurement & Sourcing
• Manufacturing Operations
• Inventory & Warehouse Management
• Transportation & Distribution
• Cold Chain Management
• Commercial Supply Planning

By Deployment

• Cloud-Based
• On-Premise
• Hybrid

By End User

• Pharmaceutical Manufacturers
• Biotechnology Companies
• CDMOs/CMOs
• Pharmaceutical Distributors
• Logistics & Cold Chain Providers

By Region

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• Saudi Arabia
• South Africa
• UAE
• Rest of MEA
• South America
• Argentina
• Brazil
• Rest of South America

Geography Breakdown

• North America accounted for the largest share of the AI in pharmaceutical supply chain market in 2025, representing approximately 42% of the global total. This dominant position reflects the region's early and extensive adoption of advanced digital technologies within healthcare and life sciences logistics. The maturity of its pharmaceutical ecosystem, combined with strong investments in artificial intelligence, data analytics, and automation, has enabled North America to establish a highly efficient and technology-driven supply chain infrastructure.
• The United States was the primary driver of this regional leadership, largely due to aggressive and sustained investments in digital transformation across the pharmaceutical sector. Major American pharmaceutical manufacturers have increasingly integrated predictive algorithms into their supply chain operations to enhance demand forecasting, optimize inventory levels, and reduce the risk of disruptions. Canada also played a significant role in strengthening North America's dominance in this market. The country has made substantial progress in upgrading its national healthcare databases and digital health infrastructure to support more advanced tracking and data-sharing systems.

Leading Market Participants

• Accenture
• Amazon Web Services
• Blue Yonder
• Deloitte
• Google Cloud
• IBM
• Infor
• Kinaxis
• Logility
• Microsoft
• o9 Solutions
• Oracle
• project44
• SAP
• TCS
• Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global AI in Pharma Supply Chain Market

Chapter 2. Report Description

• 2.1. Research Framework
  • 2.1.1. Research Objective
  • 2.1.2. Market Definitions
  • 2.1.3. Market Segmentation
• 2.2. Research Methodology
  • 2.2.1. Market Size Estimation
  • 2.2.2. Qualitative Research
    • 2.2.2.1. Primary & Secondary Sources
  • 2.2.3. Quantitative Research
    • 2.2.3.1. Primary & Secondary Sources
  • 2.2.4. Breakdown of Primary Research Respondents, By Region
  • 2.2.5. Data Triangulation
  • 2.2.6. Assumption for Study

Chapter 3. Global AI in Pharma Supply Chain Market Overview

• 3.1. Industry Value Chain Analysis
  • 3.1.1. AI Software & Platform Providers
  • 3.1.2. Data & Analytics Providers
  • 3.1.3. Cloud Infrastructure Providers
  • 3.1.4. System Integrators & Consulting Firms
  • 3.1.5. Pharmaceutical Manufacturers, Distributors & Logistics Providers
• 3.2. Industry Outlook
  • 3.2.1. Digitalization of Pharmaceutical Logistics
  • 3.2.2. Rising Focus on Demand Sensing & Drug Shortage Prediction
  • 3.2.3. Serialization, Traceability & Anti-Counterfeiting Mandates
  • 3.2.4. Expansion of Cold Chain & Direct-to-Patient Distribution
• 3.3. PESTLE Analysis
• 3.4. Porter's Five Forces Analysis
  • 3.4.1. Bargaining Power of Suppliers
  • 3.4.2. Bargaining Power of Buyers
  • 3.4.3. Threat of Substitutes
  • 3.4.4. Threat of New Entrants
  • 3.4.5. Degree of Competition
• 3.5. Market Growth and Outlook
  • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
• 3.6. Market Attractiveness Analysis
  • 3.6.1. By Component
• 3.7. Actionable Insights (Analyst's Recommendations)

Chapter 4. Competition Dashboard

• 4.1. Market Concentration Rate
• 4.2. Company Market Share Analysis (Value %), 2025
• 4.3. Competitor Mapping & Benchmarking

Chapter 5. Global AI in Pharma Supply Chain Market Analysis

• 5.1. Market Dynamics and Trends
  • 5.1.1. Growth Drivers
  • 5.1.2. Restraints
  • 5.1.3. Opportunity
  • 5.1.4. Key Trends
• 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 5.2.1. By Component
    • 5.2.1.1. Key Insights
      • 5.2.1.1.1. Software
      • 5.2.1.1.2. Services
  • 5.2.2. By Technology
    • 5.2.2.1. Key Insights
      • 5.2.2.1.1. Machine Learning
      • 5.2.2.1.2. Deep Learning
      • 5.2.2.1.3. Predictive Analytics
      • 5.2.2.1.4. Natural Language Processing
      • 5.2.2.1.5. Computer Vision
      • 5.2.2.1.6. Generative AI
  • 5.2.3. By Supply Chain Stage
    • 5.2.3.1. Key Insights
      • 5.2.3.1.1. Procurement & Sourcing
      • 5.2.3.1.2. Manufacturing Operations
      • 5.2.3.1.3. Inventory & Warehouse Management
      • 5.2.3.1.4. Transportation & Distribution
      • 5.2.3.1.5. Cold Chain Management
      • 5.2.3.1.6. Commercial Supply Planning
  • 5.2.4. By Deployment
    • 5.2.4.1. Key Insights
      • 5.2.4.1.1. Cloud-Based
      • 5.2.4.1.2. On-Premise
      • 5.2.4.1.3. Hybrid
  • 5.2.5. By End User
    • 5.2.5.1. Key Insights
      • 5.2.5.1.1. Pharmaceutical Manufacturers
      • 5.2.5.1.2. Biotechnology Companies
      • 5.2.5.1.3. CDMOs/CMOs
      • 5.2.5.1.4. Pharmaceutical Distributors
      • 5.2.5.1.5. Logistics & Cold Chain Providers
  • 5.2.6. By Region
    • 5.2.6.1. Key Insights
      • 5.2.6.1.1. North America
        • 5.2.6.1.1.1. The U.S.
        • 5.2.6.1.1.2. Canada
        • 5.2.6.1.1.3. Mexico
      • 5.2.6.1.2. Europe
        • 5.2.6.1.2.1. Western Europe
          • 5.2.6.1.2.1.1. The UK
          • 5.2.6.1.2.1.2. Germany
          • 5.2.6.1.2.1.3. France
          • 5.2.6.1.2.1.4. Italy
          • 5.2.6.1.2.1.5. Spain
          • 5.2.6.1.2.1.6. Rest of Western Europe
        • 5.2.6.1.2.2. Eastern Europe
          • 5.2.6.1.2.2.1. Poland
          • 5.2.6.1.2.2.2. Russia
          • 5.2.6.1.2.2.3. Rest of Eastern Europe
      • 5.2.6.1.3. Asia Pacific
        • 5.2.6.1.3.1. China
        • 5.2.6.1.3.2. India
        • 5.2.6.1.3.3. Japan
        • 5.2.6.1.3.4. Australia & New Zealand
        • 5.2.6.1.3.5. South Korea
        • 5.2.6.1.3.6. ASEAN
        • 5.2.6.1.3.7. Rest of Asia Pacific
      • 5.2.6.1.4. Middle East & Africa (MEA)
        • 5.2.6.1.4.1. Saudi Arabia
        • 5.2.6.1.4.2. South Africa
        • 5.2.6.1.4.3. UAE
        • 5.2.6.1.4.4. Rest of MEA
      • 5.2.6.1.5. South America
        • 5.2.6.1.5.1. Argentina
        • 5.2.6.1.5.2. Brazil
        • 5.2.6.1.5.3. Rest of South America

Chapter 6. North America AI in Pharma Supply Chain Market Analysis

• 6.1. Market Dynamics and Trends
  • 6.1.1. Growth Drivers
  • 6.1.2. Restraints
  • 6.1.3. Opportunity
  • 6.1.4. Key Trends
• 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 6.2.1. By Component
  • 6.2.2. By Technology
  • 6.2.3. By Supply Chain Stage
  • 6.2.4. By Deployment
  • 6.2.5. By End User
  • 6.2.6. By Country

Chapter 7. Europe AI in Pharma Supply Chain Market Analysis

• 7.1. Market Dynamics and Trends
  • 7.1.1. Growth Drivers
  • 7.1.2. Restraints
  • 7.1.3. Opportunity
  • 7.1.4. Key Trends
• 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 7.2.1. By Component
  • 7.2.2. By Technology
  • 7.2.3. By Supply Chain Stage
  • 7.2.4. By Deployment
  • 7.2.5. By End User
  • 7.2.6. By Country

Chapter 8. Asia Pacific AI in Pharma Supply Chain Market Analysis

• 8.1. Market Dynamics and Trends
  • 8.1.1. Growth Drivers
  • 8.1.2. Restraints
  • 8.1.3. Opportunity
  • 8.1.4. Key Trends
• 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 8.2.1. By Component
  • 8.2.2. By Technology
  • 8.2.3. By Supply Chain Stage
  • 8.2.4. By Deployment
  • 8.2.5. By End User
  • 8.2.6. By Country

Chapter 9. Middle East & Africa AI in Pharma Supply Chain Market Analysis

• 9.1. Market Dynamics and Trends
  • 9.1.1. Growth Drivers
  • 9.1.2. Restraints
  • 9.1.3. Opportunity
  • 9.1.4. Key Trends
• 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 9.2.1. By Component
  • 9.2.2. By Technology
  • 9.2.3. By Supply Chain Stage
  • 9.2.4. By Deployment
  • 9.2.5. By End User
  • 9.2.6. By Country

Chapter 10. South America AI in Pharma Supply Chain Market Analysis

• 10.1. Market Dynamics and Trends
  • 10.1.1. Growth Drivers
  • 10.1.2. Restraints
  • 10.1.3. Opportunity
  • 10.1.4. Key Trends
• 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 10.2.1. By Component
  • 10.2.2. By Technology
  • 10.2.3. By Supply Chain Stage
  • 10.2.4. By Deployment
  • 10.2.5. By End User
  • 10.2.6. By Country

Chapter 11. Company Profile (Company Overview, Company Timeline, Organization Structure, Key Product landscape, Financial Matrix, Key Customers/Sectors, Key Competitors, SWOT Analysis, Contact Address, and Business Strategy Outlook)

• 11.1. Accenture
• 11.2. Amazon Web Services
• 11.3. Blue Yonder
• 11.4. Deloitte
• 11.5. Google Cloud
• 11.6. IBM
• 11.7. Infor
• 11.8. Kinaxis
• 11.9. Logility
• 11.10. Microsoft
• 11.11. o9 Solutions
• 11.12. Oracle
• 11.13. project44
• 11.14. SAP
• 11.15. TCS
• 11.16. Other Prominent Players

Chapter 12. Annexure

• 12.1. List of Secondary Sources
• 12.2. Key Country Markets- Macro Economic Outlook/Indicators